Is Benadryl a Benzo? Antihistamine vs Benzodiazepine

Benadryl is not a benzodiazepine. Its active ingredient, diphenhydramine, is a first-generation antihistamine that blocks histamine receptors, while benzodiazepines like diazepam (Valium) and alprazolam (Xanax) work on an entirely different receptor system in the brain. The confusion is understandable, though, because both drug classes can make you drowsy, both are sometimes used for anxiety or sleep, and both carry real risks when misused. The similarity ends at the surface.

Why People Mix Them Up

The overlap in how these drugs feel is the main reason people wonder whether Benadryl belongs in the benzodiazepine family. Take a standard dose of diphenhydramine and you’ll get sedated. Take a standard dose of diazepam and you’ll also get sedated. A head-to-head study comparing diphenhydramine (50 mg) and diazepam (10 mg) found that both drugs reduced alertness and skin conductance compared to placebo, with diphenhydramine actually producing a larger drop in subjective alertness than diazepam did.¹ If you’ve taken Benadryl and felt knocked out, you might reasonably assume it’s doing something similar to a sedative like Valium. But the machinery behind the sedation is completely different.

Adding to the confusion, both drugs sometimes show up in the same clinical contexts. Diphenhydramine is sold over the counter as a sleep aid (ZzzQuil, Unisom SleepGels, and the “PM” versions of many pain relievers are all just diphenhydramine). Benzodiazepines like temazepam are prescribed for insomnia. A related antihistamine, hydroxyzine, is prescribed for generalized anxiety disorder, a condition more commonly treated with benzodiazepines. A Cochrane review found hydroxyzine roughly equivalent to benzodiazepines for anxiety relief.² When antihistamines and benzodiazepines are used for the same problems and produce similar-feeling sedation, the lines get blurry for anyone who isn’t a pharmacist.

How They Actually Work

Benzodiazepines target GABA-A receptors, the brain’s main inhibitory system. They don’t activate these receptors directly but instead amplify the effect of GABA, the neurotransmitter your brain naturally uses to calm neural activity.³ The result is a powerful reduction in anxiety, muscle tension, and wakefulness. One study showed that diazepam shifts the receptor toward a state where GABA binds more effectively, roughly doubling the receptor’s sensitivity to GABA.⁴ This is also why benzodiazepines are effective anticonvulsants and muscle relaxants: they’re tuning up the brain’s entire braking system.

Diphenhydramine works through a completely separate pathway. It blocks H1 histamine receptors in the brain, which is why it stops allergic reactions like hives and sneezing. But histamine also plays a major role in keeping you awake and alert. When you block those receptors, sleepiness follows as a side effect. A brain-imaging study using PET scans found that a single 50 mg dose of diphenhydramine taken the night before still occupied about 45% of H1 receptors in the brain the following morning, compared to about 17% for a newer antihistamine.⁵ That persistent receptor blockade is why people often feel groggy the morning after taking Benadryl.

Diphenhydramine also has strong anticholinergic activity, meaning it blocks acetylcholine, another neurotransmitter involved in memory, attention, and certain body functions like saliva production and bladder control. This is what causes the dry mouth, blurred vision, and constipation that benzodiazepines generally don’t produce. The anticholinergic effects are a useful clinical fingerprint: if you’re experiencing dry mouth and can’t urinate along with drowsiness, that’s an antihistamine profile, not a benzodiazepine one.

Driving Impairment Compared to Alcohol

One area where diphenhydramine’s effects are genuinely alarming is behind the wheel. A randomized trial using the Iowa Driving Simulator tested participants after they took diphenhydramine (50 mg), fexofenadine (a non-sedating antihistamine), alcohol to a blood concentration of roughly 0.1%, or placebo. Driving performance was worst after diphenhydramine, meaning a standard dose of Benadryl impaired driving more than being legally drunk.⁶ Fexofenadine, a second-generation antihistamine, had no measurable effect on driving.

This is a comparison that matters for everyday decisions. Many people take Benadryl and assume they’re fine to drive because it’s over the counter. Benzodiazepines carry explicit warnings about operating machinery. Diphenhydramine carries them too, but because you can buy it without a prescription, people tend to take those warnings less seriously. The driving data suggest they shouldn’t.

Can You Get Dependent on Benadryl?

Benzodiazepine dependence is well known. Physical dependence can develop within weeks of daily use, and withdrawal from high doses can be medically dangerous, involving seizures. This is one of the main reasons benzodiazepines require a prescription and are classified as controlled substances.

Diphenhydramine is not a controlled substance, but that doesn’t mean dependence can’t happen. Case reports describe people taking extremely high daily doses of diphenhydramine for months or years and developing physical dependence. One published case involved a woman taking 750 to 1,000 mg per day (15 to 20 times the standard dose) who experienced altered mental status, tremors, rapid heart rate, and severe agitation upon stopping abruptly, requiring hospitalization and a benzodiazepine taper to manage the withdrawal.⁷ A systematic review of over-the-counter drug misuse found that reported dependence cases typically involved doses above 1,000 mg per day sustained over months, with withdrawal symptoms including insomnia, nausea, sweating, and restlessness.⁸

The dependence profiles differ in character. Benzodiazepine withdrawal can be life-threatening, and physical dependence develops on therapeutic doses. Diphenhydramine dependence appears to develop primarily at very high, sustained doses well beyond what anyone would take for allergies. But the pattern of abuse exists, and clinicians sometimes underestimate it precisely because diphenhydramine isn’t classified alongside benzodiazepines.

Tolerance Builds Fast

One reason people escalate diphenhydramine doses is that tolerance to its sedative effects develops rapidly. A controlled study found that while diphenhydramine significantly increased sleepiness and impaired performance on day one, these effects were indistinguishable from placebo by day four.⁹ Another study confirmed this timeline, showing that sedation and performance impairment from diphenhydramine disappeared by the third day of use.¹⁰

This is a meaningful difference from benzodiazepines, where tolerance to sedation also develops but typically over weeks rather than days, and tolerance to the anxiolytic effects develops more slowly or incompletely. With diphenhydramine, the sleep-promoting effect can essentially vanish within three to four nights, which makes it a poor choice for ongoing insomnia even if it works well the first night. A clinical trial comparing diphenhydramine to temazepam (a benzodiazepine sleep aid) found that diphenhydramine reduced the time to fall asleep better than placebo and provided longer sleep duration than temazepam by the fifth night, but both drugs caused residual daytime drowsiness.¹¹ The rapid tolerance means that someone using Benadryl as a nightly sleep aid may stop feeling the benefit quickly but continue experiencing next-day grogginess and anticholinergic side effects.

The Anticholinergic Dementia Risk

This is arguably the most important safety distinction between diphenhydramine and benzodiazepines, and it’s one most people have never heard of. Diphenhydramine’s anticholinergic activity has been linked to increased dementia risk with heavy cumulative use. A large prospective study tracking over 3,400 older adults for an average of about seven years found that people with the highest cumulative exposure to strong anticholinergic drugs had roughly a 54% higher risk of developing dementia compared to non-users.¹² The risk followed a dose-response pattern: the more you used, the higher the risk, and the effect was consistent regardless of which anticholinergic was involved.¹³

A more recent study focused specifically on first-generation antihistamines like diphenhydramine in patients with allergic rhinitis and found elevated dementia risk that climbed with cumulative dose. At the highest exposure levels, the risk was about 51% higher than in non-users.¹⁴ These are observational findings, not proof of causation, but the consistency and dose-response relationship across multiple studies make this a signal worth taking seriously.

Benzodiazepines have their own links to cognitive decline in older adults, but the mechanism is different. The anticholinergic burden is specific to drugs like diphenhydramine. Second-generation antihistamines such as cetirizine (Zyrtec) and loratadine (Claritin) largely avoid the brain’s histamine receptors and don’t carry the same anticholinergic load, which is why allergists have long recommended them over first-generation options.

Older Adults and the Beers List

The American Geriatrics Society maintains the Beers Criteria, a regularly updated list of medications considered potentially inappropriate for older adults. Diphenhydramine is on it, specifically because of its anticholinergic effects, sedation, and risks of confusion and falls in people over 65.¹⁵ Benzodiazepines are also on the list, for overlapping but distinct reasons centered on fall risk and cognitive impairment.

Despite the Beers Criteria listing, over-the-counter sleep aids containing diphenhydramine or the related antihistamine doxylamine remain extremely popular among older adults. A study of older adults using OTC sleep medications found that more than half had used a diphenhydramine or doxylamine product within the past month, and those users were less likely to be aware of any safety risks compared to non-users.¹⁶ The OTC status creates a false sense of safety. People assume that if it’s available without a prescription, it can’t be as risky as a “real” sedative. For older adults especially, the evidence suggests otherwise.

What Happens in Overdose

Overdose is another area where the two drug classes diverge. Benzodiazepine overdose, taken alone, is rarely fatal in healthy adults because the drugs have a relatively high ceiling before they suppress breathing. The real danger with benzodiazepines comes from combining them with other central nervous system depressants like opioids or alcohol, which dramatically raises the risk of fatal respiratory depression.¹⁷

Diphenhydramine overdose looks different. High doses produce what’s called anticholinergic toxidrome: agitation, hallucinations, rapid heart rate, high blood pressure, dilated pupils, dry flushed skin, and in severe cases, seizures and cardiac arrhythmias. Treatment in the emergency department sometimes involves physostigmine (which counters the anticholinergic effects) along with supportive care. Ironically, benzodiazepines are one of the standard treatments given for the agitation and seizures caused by diphenhydramine overdose, though clinicians have explored adding other sedatives to avoid the respiratory depression that high-dose benzodiazepines can cause in that setting.¹⁸

Paradoxical Reactions

Some people, particularly children and certain adults, experience the opposite of sedation when they take diphenhydramine. Instead of drowsiness, they become hyperactive, agitated, or restless. This paradoxical excitation has been linked to genetic differences in how the drug is metabolized. Case reports describe individuals who are ultrarapid metabolizers of CYP2D6, a liver enzyme involved in breaking down diphenhydramine, and who experienced excitation rather than sedation. The working hypothesis is that faster metabolism converts diphenhydramine into a stimulating metabolite at an abnormally high rate.¹⁹

This phenomenon doesn’t have a direct parallel with benzodiazepines, though paradoxical reactions to benzodiazepines (agitation, aggression) do occur rarely. With diphenhydramine, paradoxical excitation seems to be more common in young children, which is one reason pediatric use of the drug has come under greater scrutiny. Parents who give Benadryl expecting it to calm a child and instead see the child become wired are witnessing this pharmacogenetic variation in action.

Choosing Between Sleep Aids

If you’re reaching for Benadryl at bedtime because you can’t sleep, understanding the distinction from benzodiazepines has practical implications. Benzodiazepine sleep aids like temazepam are prescription drugs with known dependence risk, but they have established dosing guidelines, prescriber oversight, and a body of evidence on duration of use. Diphenhydramine is available everywhere, costs almost nothing, and is marketed aggressively as a sleep aid, but the rapid tolerance means it stops working within days, the anticholinergic load builds with repeated use, and the next-morning receptor occupancy means you may feel foggy long after you’ve woken up.

For allergies, the choice is clearer. Second-generation antihistamines handle allergic rhinitis and hives without the brain fog, driving impairment, or anticholinergic effects. Diphenhydramine remains useful for acute allergic reactions and anaphylaxis, where its rapid onset matters, but there’s little reason to use it daily for seasonal allergies when non-sedating options exist.²⁰

The broader takeaway is that “not a benzodiazepine” doesn’t mean “safe to take casually.” Diphenhydramine has its own set of risks that are distinct from but not necessarily less concerning than those of controlled sedatives, particularly with repeated use and especially in older adults. The fact that it sits on a pharmacy shelf without a prescription creates a gap between how people perceive its safety and what the evidence actually shows.